Literature DB >> 11916854

Ryanodine-induced structural alterations in the RyR channel suggested by neomycin block.

Fiona Mead1, Alan J Williams.   

Abstract

In Mead and Williams, (Biophys. J. 82:1953-1963, 2002) we have reported that neomycin is a potent partial blocker of single purified sheep cardiac SR calcium release channels. Neomycin is unusual in that it is capable of blocking when applied to either the cytosolic or the luminal face of the channel. Block at either aspect of the channel is both concentration- and voltage-dependent, but exhibits different blocking parameters. In this study we have investigated the actions of neomycin on ion handling in the ryanodine-modified channel. Neomycin is more effective at the cytosolic face, having a Kb(0) value of 534.9 +/- 35.17 nM compared with a Kb(0) value of 971.5 +/- 66.62 nM for the luminal face. The voltage dependence also differs at the two sites. Values of zdelta for cytosolic and luminal neomycin are 1.09 +/- 0.04 and -0.57 +/- 0.03, respectively. The interaction of neomycin with the ryanodine-modified channel differs notably from that in the unmodified channel. Voltage-dependent relief of block is not observed after ryanodine modification, and the luminal blocking characteristics are altered. This suggests that ryanodine induces changes at the luminal mouth of the channel and may confer increased rigidity to the channel protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916854      PMCID: PMC1301992          DOI: 10.1016/S0006-3495(02)75545-8

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  15 in total

1.  Block of the ryanodine receptor channel by neomycin is relieved at high holding potentials.

Authors:  Fiona Mead; Alan J Williams
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Charged local anesthetics block ionic conduction in the sheep cardiac sarcoplasmic reticulum calcium release channel.

Authors:  A Tinker; A J Williams
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

3.  Using large organic cations to probe the nature of ryanodine modification in the sheep cardiac sarcoplasmic reticulum calcium release channel.

Authors:  A Tinker; A J Williams
Journal:  Biophys J       Date:  1993-10       Impact factor: 4.033

4.  Ryanoid modification of the cardiac muscle ryanodine receptor channel results in relocation of the tetraethylammonium binding site.

Authors:  B Tanna; W Welch; L Ruest; J L Sutko; A J Williams
Journal:  J Gen Physiol       Date:  2001-05       Impact factor: 4.086

5.  Localization of the high and low affinity [3H]ryanodine binding sites on the skeletal muscle Ca2+ release channel.

Authors:  C Callaway; A Seryshev; J P Wang; K J Slavik; D H Needleman; C Cantu; Y Wu; T Jayaraman; A R Marks; S L Hamilton
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

6.  Interactions of a reversible ryanoid (21-amino-9alpha-hydroxy-ryanodine) with single sheep cardiac ryanodine receptor channels.

Authors:  B Tanna; W Welch; L Ruest; J L Sutko; A J Williams
Journal:  J Gen Physiol       Date:  1998-07       Impact factor: 4.086

7.  Large tetraalkyl ammonium cations produce a reduced conductance state in the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel.

Authors:  A Tinker; A R Lindsay; A J Williams
Journal:  Biophys J       Date:  1992-05       Impact factor: 4.033

8.  How does ryanodine modify ion handling in the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel?

Authors:  A R Lindsay; A Tinker; A J Williams
Journal:  J Gen Physiol       Date:  1994-09       Impact factor: 4.086

9.  Ionic blockage of sodium channels in nerve.

Authors:  A M Woodhull
Journal:  J Gen Physiol       Date:  1973-06       Impact factor: 4.086

10.  Effects of local anesthetics on single channel behavior of skeletal muscle calcium release channel.

Authors:  L Xu; R Jones; G Meissner
Journal:  J Gen Physiol       Date:  1993-02       Impact factor: 4.086

View more
  6 in total

1.  Two rings of negative charges in the cytosolic vestibule of type-1 ryanodine receptor modulate ion fluxes.

Authors:  Le Xu; Ying Wang; Dirk Gillespie; Gerhard Meissner
Journal:  Biophys J       Date:  2005-10-20       Impact factor: 4.033

2.  The ryanodine receptor pore blocker neomycin also inhibits channel activity via a previously undescribed high-affinity Ca(2+) binding site.

Authors:  Derek R Laver; Tomoyo Hamada; James D Fessenden; Noriaki Ikemoto
Journal:  J Membr Biol       Date:  2007-09-18       Impact factor: 1.843

3.  Electrostatic mechanisms underlie neomycin block of the cardiac ryanodine receptor channel (RyR2).

Authors:  Fiona C Mead; Alan J Williams
Journal:  Biophys J       Date:  2004-09-10       Impact factor: 4.033

4.  Protecting Mammalian Hair Cells from Aminoglycoside-Toxicity: Assessing Phenoxybenzamine's Potential.

Authors:  Paromita Majumder; Paulette A Moore; Guy P Richardson; Jonathan E Gale
Journal:  Front Cell Neurosci       Date:  2017-04-18       Impact factor: 5.505

5.  CapZ integrates several signaling pathways in response to mechanical stiffness.

Authors:  Christopher Solís; Brenda Russell
Journal:  J Gen Physiol       Date:  2019-02-26       Impact factor: 4.086

6.  Insights into the gating mechanism of the ryanodine-modified human cardiac Ca2+-release channel (ryanodine receptor 2).

Authors:  Saptarshi Mukherjee; N Lowri Thomas; Alan J Williams
Journal:  Mol Pharmacol       Date:  2014-07-07       Impact factor: 4.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.